Journals / Meme Sağlığı Dergisi / 2009 / Cilt: 5 - Sayı: 2

Factors that effect overall and disease free survival in breast cancer patients

Meme kanserinde genel ve hastalıksız sağ kalımı etkileyen faktörlerin analizi

Pages
98–103
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Purpose of this study was to determine the factors that eff ect overall and disease free survival in the patients with breast cancer in a long period of time in a single center.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: Prognostic factors are important in the follow-up of breast cancer patients and in the arrangement of adjuvant therapies.
📊
Key Findings & Data:Patients and Methods: Breast cancer patients who operated on Ankara Numune Research and Training Hospital at 4th Surgical Clinic, between January 1992 and January 2006 were investigated.
💡
Conclusion & Impact:Purpose of this study was to determine the factors that eff ect overall and disease free survival in the patients with breast cancer in a long period of time in a single center.
🔬Design:Research Article
📍Scope:2006 Verileri
⚙️Variables:Sağkalım · Meme neoplazmları · Geriyedönük çalışma

Abstract

Purpose: Prognostic factors are important in the follow-up of breast cancer patients and in the arrangement of adjuvant therapies. Purpose of this study was to determine the factors that eff ect overall and disease free survival in the patients with breast cancer in a long period of time in a single center. Patients and Methods: Breast cancer patients who operated on Ankara Numune Research and Training Hospital at 4th Surgical Clinic, between January 1992 and January 2006 were investigated. There were 214 patients and the factors that eff ect overall and disease free survival rates were analyzed in univariate and multivariete survival analyses. Patients who undergone a modified radical mastectomy and who have pathology report as infiltrative ductal carcinoma were included in the study. Results: Mean follow-up time was 57 (12-192) months. Five years overall survival was 145 (133-157) months and five years disease free survival rate was 127 (113- 141) months. Locoregional recurrence rate was 9.3% (20 patients) and systemic recurrence rate was 27.5% (59 patients). General recurrence rate was 31.3% (67 patients). Grade and free tumor cell in axilla were the significant factors that effect overall survival rate and pN and grade were the significant factors that effect disease feee survival rate in multivariete analyses. Free tumor cell in axilla means that extramammary fatty tissues were infiltrated by tumor cells. Conclusion: In patients with modified radical mastectomy, grade and free tumor cell in axilla were the significant factors that eff ect overall and disease survival rate beside the most popular factor nodal status.

Özet

Amaç: Prognostik faktörler meme kanserli hastaların izleminde ve adjuvan tedavilerin düzenlenmesinde önemlidir. Çalışmamızda tek merkezli, uzun dönem takipli hastalarda genel ve hastalıksız sağ kalımı etkileyen prognostik faktörlerin belirlenmesini amaçladık. Hastalar ve Yöntem: Ocak 1992- Ocak 2006 yılları arasında Ankara Numune Eğitim ve Araştırma Hastanesi 4. Cerrahi Kliniğinde meme kanseri tanısı ile ameliyat olmuş 214 ardışık hasta geriye dönük olarak incelendi. Homojen bir grup oluşturmak amacıyla sadece modifiye radikal mastektomi yapılan ve patoloji sonucu infiltratif duktal karsinom olanlar çalışmaya alınmıştır. Genel ve hastalıksız sağ kalımı etkileyen faktörler tek değişkenli ve çok değişkenli sağ kalım analizleri yapılarak belirlendi. Bulgular: Ortalama takip süresi 57 (12-192) ay olup, 5 yıllık genel sağ kalım 145 (133-157) ay, hastalıksız sağ kalım 127 (113-141) ay olarak bulunmuştur. Yerel yineleme oranı %9.3 (20 hasta), sistemik yineleme oranı %27.5 (59 hasta) olup, genel yineleme oranı %31.3 (67 hasta)'tür. Çok değişkenli analizde genel sağ kalımı etkileyen anlamlı faktörler grad ve aksillada serbest tümör hücresi olması; hastalıksız sağ kalımı etkileyen anlamlı faktörler ise nodal statü (pN) ve grad olarak bulunmuştur (p<0.001). Aksillada serbest tümör hücresi ya da yağ infiltrasyonu pozitif kabul edilen hastalarda meme dışındaki yağ dokusunda tümör hücreleri gözlenmiştir. Sonuç: Modifiye radikal mastektomi yapılan hastalarda genel ve hastalıksız sağ kalımı etkileyen faktörleri araştırdığımız bu çalışmada yaygın olarak kabul gören nodal durumun yanısıra grad, aksiller yağ dokusu tutulumu anlamlı faktörler olarak karşımıza çıkmıştır.

🔖

Cite This Article

DAĞLAR, G., YÜKSEK, Y. N., GÖZALAN, U., DOĞANAY, M., KAMA, N. A. (2009). Factors that effect overall and disease free survival in breast cancer patients. Meme Sağlığı Dergisi, Cilt: 5 - Sayı: 2, 98–103. https://ajindex.com/articles/278190

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Soerjomataram I, Louwman MW, Ribot GJ, Roukema JA, Coebergh JW. An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat 2008; 107: 309-330. (PMID: 17377838
  2. Carter CL, Allen C, Heuson D. Relation of tumour size, lymph node status and survival in 24 740 breast cancer cases. Cancer 1989; 63: 181-7 (PMID: 2910416
  3. Warwick J, Tabbar L, Vitak B Duff y SW. Time dependent eff ects on survival in breast carcinoma: results of 20 years of follow-up from the Swedish Two-County Study. Cancer 2004; 100: 1331-1336. (PMID: 15042664
  4. Weiss RB, Woolf SH, Demakos E, Holland JF, Berry DA, Falkson G, Cirrincione CT, Robbins A, Bothun S, Henderson IC, Norton L, Cancer and Leukkemia Group B. Natural history of more than 20 years of node positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B. J Clin Oncol 2003; 21: 1825-1835. ( PMID: 12721260
  5. Van der Wal BC, Butzelaar RM, van der Meij S, Boermeester MA. Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer. Eur J Surg Oncol 2002; 28: 481-9. (PMID: 12217299
  6. Arrigada R, Le MG, Dunant A, Tubiana M, Contesso G. Twenty-five years of follow-up in patients with operable breast carcinoma: correlation between clinicopathological factors and the risk of death in each 5- year period. Cancer 2006; 106: 743-750. (PMID: 16411216
  7. Fisher ER, Anderson S, Tan-Chiu E, Fisher B, Eaton L, Wolmark N. Fifteenyear prognostic discriminants for invasive breast carcinoma: National Surgical Adjuvant Breast and Bowel Project Protocol-06. Cancer 2001; 91: 1679-1687. (PMID: 11309768
  8. Fisher B, Bauer M, Wickerham DL, Redmond CK, Fisher ER, Cruz AB, Foster R, Gardner B, Lerner H, Margolese R, et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. Cancer 1983; 52: 1551-7. (PMID: 6352003
  9. Fisher ER, Costantino J, Fisher B, Redmond C. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 4) Discriminants for 15 year survival. Cancer 1993; 71: 2141-50. (PMID: 8443763
  10. Singletary SE, Allred C, Ashley P, Basset LW, Berry D, Bland KI, Borgen PI, Clark GM, Edge SB, Hayes DF, Hughes LL, Hutter RV, Morrow M, Page DL, Recht A, Theriault RL, Thor A, Weaver DL, Wieand HS, Greene FL. Staging system for breast cancer: revisions for the 6th e